From: Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer
Gene | SNP | Genotype | DFS HR (95% CI) | P | DFS Adjusted HR (95% CI) | P |
---|---|---|---|---|---|---|
MEG3 | rs10132552 | TT | 1 | Â | 1 | Â |
TC + CC | 0.193(0.042–0.884) | 0.034* | 0.127(0.22–0.728) | 0.02* | ||
rs941576 | AA | 1 | Â | 1 | Â | |
AG + GG | 0.257(0.069–0.951) | 0.042* | 0.183(0.041–0.807) | 0.025* | ||
rs7158663 | GG | 1 | Â | 1 | Â | |
AG + AA | 0.124(0.016–0.964) | 0.046* | 0.155(0.019–1.236) | 0.078 | ||
rs10132552+ rs941576 | TT + AA | 1 |  | 1 |  | |
others | 0.257(0.069–0.951) | 0.042* | 0.183(0.041–0.807) | 0.025* | ||
rs10132552+ rs941576 + rs7158663 | TT + AA+GG | 1 |  | 1 |  | |
Others | 0.175(0.047–0.648) | 0.009* | 0.116(0.025–0.552) | 0.007* |